HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin Li Selected Research

N- (3- bromophenyl)- 7- methoxy- 6- (3- (3- methoxypyrrolidin- 1- yl)propoxy)quinazolin- 4- amine

2/2009Antitumor activity of a novel EGFR tyrosine kinase inhibitor against human lung carcinoma in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lin Li Research Topics

Disease

573Neoplasms (Cancer)
12/2022 - 09/2002
115Inflammation (Inflammations)
09/2022 - 08/2003
98Infections
06/2022 - 05/2005
97Breast Neoplasms (Breast Cancer)
02/2022 - 01/2005
94Neoplasm Metastasis (Metastasis)
03/2022 - 08/2002
55Carcinogenesis
04/2022 - 04/2009
54Alzheimer Disease (Alzheimer's Disease)
01/2022 - 08/2003
46Type 2 Diabetes Mellitus (MODY)
11/2022 - 08/2006
44Lung Neoplasms (Lung Cancer)
11/2022 - 08/2002
44Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 08/2002
39Cardiovascular Diseases (Cardiovascular Disease)
11/2022 - 02/2006
39Insulin Resistance
11/2022 - 01/2005
37Parkinson Disease (Parkinson's Disease)
07/2022 - 06/2011
36Carcinoma (Carcinomatosis)
06/2022 - 06/2004
33Pain (Aches)
10/2022 - 08/2002
31COVID-19
08/2022 - 01/2020
31Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 01/2010
30Fibrosis (Cirrhosis)
09/2022 - 02/2004
30Body Weight (Weight, Body)
05/2022 - 04/2007
28Ischemia
05/2022 - 04/2003
27Stomach Neoplasms (Stomach Cancer)
06/2022 - 01/2013
27Hepatocellular Carcinoma (Hepatoma)
06/2022 - 03/2002
27Adenocarcinoma
01/2022 - 07/2006
26Necrosis
07/2022 - 03/2007
25Melanoma (Melanoma, Malignant)
01/2022 - 01/2014
24Atherosclerosis
07/2022 - 06/2009
24Virus Diseases (Viral Diseases)
04/2022 - 05/2005
24Wounds and Injuries (Trauma)
04/2022 - 05/2008
24Neuralgia (Stump Neuralgia)
01/2021 - 06/2010
23Stroke (Strokes)
06/2022 - 05/2012
23Hemorrhage
05/2022 - 10/2003
23Myocardial Infarction
01/2022 - 07/2006
23Hypertension (High Blood Pressure)
01/2022 - 06/2007
23Prostatic Neoplasms (Prostate Cancer)
01/2022 - 05/2005
22Cognitive Dysfunction
01/2022 - 09/2006
21Mitochondrial Diseases (Mitochondrial Disease)
05/2022 - 06/2010
20Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 04/2009
20Ovarian Neoplasms (Ovarian Cancer)
11/2021 - 12/2007
19Coronary Disease (Coronary Heart Disease)
11/2022 - 02/2011
19Hypoxia (Hypoxemia)
07/2022 - 04/2003
18Pancreatic Neoplasms (Pancreatic Cancer)
03/2022 - 06/2005
18Adenocarcinoma of Lung
03/2021 - 11/2008
17Ischemic Stroke
07/2022 - 05/2010
17Hyperalgesia
03/2022 - 08/2008
17Obesity
02/2022 - 05/2003
17Acquired Immunodeficiency Syndrome (AIDS)
01/2022 - 05/2005
17Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 08/2012
17Brain Ischemia (Cerebral Ischemia)
03/2021 - 04/2003
16Heart Failure
07/2022 - 01/2012
15Glioma (Gliomas)
12/2022 - 05/2016
15Reperfusion Injury
05/2022 - 07/2004
14Myocardial Ischemia (Ischemic Heart Diseases)
07/2022 - 01/2017
14Proteinuria
07/2022 - 08/2010
14Chronic Kidney Failure (Chronic Renal Failure)
05/2022 - 01/2008
14Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 05/2008

Drug/Important Bio-Agent (IBA)

241Proteins (Proteins, Gene)FDA Link
08/2022 - 03/2002
107Pharmaceutical PreparationsIBA
02/2022 - 05/2005
93Biomarkers (Surrogate Marker)IBA
11/2022 - 03/2007
65Messenger RNA (mRNA)IBA
07/2022 - 09/2006
63Biological ProductsIBA
03/2022 - 05/2007
49MicroRNAs (MicroRNA)IBA
06/2022 - 06/2010
46CytokinesIBA
05/2022 - 05/2003
45Glucose (Dextrose)FDA LinkGeneric
11/2022 - 05/2003
38Peptides (Polypeptides)IBA
12/2022 - 09/2002
38EnzymesIBA
07/2022 - 07/2005
37Long Noncoding RNAIBA
07/2022 - 01/2018
33LipidsIBA
07/2022 - 03/2006
33Small Interfering RNA (siRNA)IBA
03/2022 - 12/2004
33Amyloid (Amyloid Fibrils)IBA
01/2022 - 03/2011
32Therapeutic UsesIBA
12/2021 - 07/2004
30RNA (Ribonucleic Acid)IBA
05/2022 - 06/2010
28DNA (Deoxyribonucleic Acid)IBA
03/2022 - 03/2007
28AntigensIBA
01/2022 - 03/2002
27AntibodiesIBA
02/2022 - 06/2005
24Insulin (Novolin)FDA Link
01/2022 - 08/2006
24VaccinesIBA
01/2022 - 11/2005
22Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 03/2007
22AntioxidantsIBA
03/2022 - 01/2006
22Antiviral Agents (Antivirals)IBA
01/2022 - 05/2005
21Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2022 - 08/2004
21Neuroprotective AgentsIBA
01/2020 - 10/2010
20LigandsIBA
07/2022 - 06/2003
20Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 09/2002
19Indicators and Reagents (Reagents)IBA
11/2022 - 10/2006
19ErbB Receptors (EGF Receptor)IBA
10/2022 - 01/2008
19Phosphotransferases (Kinase)IBA
07/2022 - 08/2013
19Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 03/2011
19Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2020 - 10/2010
17CholesterolIBA
04/2022 - 01/2005
17Transcription Factors (Transcription Factor)IBA
01/2022 - 02/2011
17trimethyloxamine (trimethylamine N-oxide)IBA
01/2022 - 05/2013
16Interleukin-6 (Interleukin 6)IBA
05/2022 - 12/2011
16Circular RNAIBA
02/2022 - 01/2018
16CateninsIBA
01/2021 - 05/2011
14CollagenIBA
09/2022 - 02/2004

Therapy/Procedure

237Therapeutics
12/2022 - 09/2004
74Drug Therapy (Chemotherapy)
09/2022 - 08/2002
34Immunotherapy
11/2022 - 06/2012
34Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2022 - 01/2007
22Radiotherapy
10/2021 - 05/2012